v3.26.1
Summary of equity attributable to Novartis AG shareholders (Details 2) - USD ($)
shares in Millions, $ in Billions
1 Months Ended 3 Months Ended
May 31, 2026
Jul. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Jul. 31, 2023
Mar. 31, 2026
Disclosure of classes of share capital [line items]            
Maximal amount of share buyback programm   $ 10.0     $ 15.0 $ 10.0
Amount of share buyback programm related to irrevocable, non-discretionary arangement 12.1   10.7 8.7